STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Cannabist Co Holdings Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

The Cannabist Company Holdings Inc. furnished a current report to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.

The information under Item 2.02 and Exhibit 99.1 is being furnished, not deemed filed under the Exchange Act or incorporated by reference unless expressly stated.

Positive
  • None.
Negative
  • None.
false000177673800017767382025-11-102025-11-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 10, 2025
____________________
THE CANNABIST COMPANY HOLDINGS INC.
(Exact Name of Registrant as specified in its charter)
____________________
British Columbia000-5629498-1488978
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
321 Billerica Road
Chelmsford, Massachusetts
01824
(Address of principal executive offices)(Zip Code)
(978) 910-1486
(Registrant’s telephone number, including area code)
Not Applicable
(Registrant’s name or former address, if change since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.



Item 2.02.     Results of Operations and Financial Condition.

On November 10, 2025, The Cannabist Company Holdings Inc., a British Columbia corporation (the “Company”), issued a press release announcing financial results for the quarter ended September 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K, which is incorporated into this item by reference.

The information furnished under this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01.     Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.         Description

99.1         Press Release, dated November 10, 2025

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CANNABIST COMPANY HOLDINGS INC.
By:/s/David Sirolly
Name:David Sirolly
Title:Chief Legal Officer and General Counsel
Date: November 10, 2025

FAQ

What did CBSTF disclose in this 8-K?

The company furnished a press release announcing financial results for the quarter ended September 30, 2025.

Which exhibit contains the Q3 2025 results for CBSTF?

Exhibit 99.1 contains the press release with the quarterly results.

Under which item was the information provided for CBSTF?

Item 2.02, Results of Operations and Financial Condition.

Is the information in the 8-K for CBSTF considered filed?

No. The Item 2.02 information and Exhibit 99.1 are furnished, not deemed filed or incorporated by reference unless expressly stated.

What is the period covered by CBSTF's results?

The quarter ended September 30, 2025.

Does CBSTF list securities under Section 12(b) in this report?

The report notes securities registered pursuant to Section 12(b): none.
Cannabist

OTC:CBSTF

CBSTF Rankings

CBSTF Latest News

CBSTF Latest SEC Filings

CBSTF Stock Data

59.38M
469.50M
4.98%
15.5%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Chelmsford